Search LFCR
Lifecore Biomedical, Inc.
NasdaqGS · CIK 1005286
Last close6.54
Daily change+0.01 (0.15%)
10 Years gain-50.97%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
LFCR · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 0525
Fundamental
32.1Momentum
n/aAcceleration
n/aConfidence
63.0Annual Revenue10
Quarterly Revenue41
Annual CFO14
Balance SheetMissing
RankingLimited
Score Breakdown
Growth3.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM-0.04%OK
Revenue CAGR 3Y5.35%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY May 25, 2025 | n/a | $40.30M | -$17.25M | -$206,000.00 | -$13.62M | n/a | n/a | n/a | -10.85% | 34.82M |
| 2025 FY May 26, 2024 | n/a | $41.85M | -$8.84M | $257,000.00 | -$18.14M | n/a | n/a | n/a | -9.18% | 36.66M |
| 2024 FY May 28, 2023 | n/a | $27.99M | -$21.80M | -$17.44M | n/a | n/a | n/a | n/a | -13.97% | 29.96M |
| 2024 FY May 29, 2022 | n/a | $39.07M | -$11.79M | -$22.59M | n/a | n/a | n/a | n/a | -3.38% | 29.47M |
| 2023 FY May 30, 2021 | n/a | $38.94M | -$8.82M | $16.47M | n/a | n/a | n/a | n/a | -1.97% | 29.29M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $557.56M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-19-009791 |
| Revenue Growth TTM | -0.04% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-19-009791 |
| Revenue CAGR 3Y | 5.35% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-19-009791 |
| Revenue CAGR 5Y | 3.18% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-19-009791 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |
| Gross Margin Delta 3Y | n/a | GrossMargin_current - GrossMargin_3Y_ago | INSUFFICIENT_HISTORY | derived |
| Operating Margin Delta 1Y | n/a | OperatingMargin_current - OperatingMargin_prior_year | INSUFFICIENT_HISTORY | derived |